• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Pipeline

Pipeline

March 29, 2020
Company Drug/Device Medical Condition Status
COVID-19 Trials and Actions
Genentech intravenous Actemra (tocilizumab) plus standard of care hospitalized adult patients with severe COVID-19 pneumonia initiation of phase 3 trial
Abbott RealTime SARS-CoV-2 EUA molecular tests SARS-CoV-2 approved by the FDA
Cepheid Xpert Xpress SARS-CoV-2 molecular diagnostic test SARS-CoV-2 approved by the FDA
Mesa Biotech Accula SARS-CoV-2 Test SARS-CoV-2 Emergency Use Authorization approved by the FDA
Bellerophon Therapeutics inhaled nitric oxide (iNO) delivery system, INOpulse SARS-CoV-2 emergency expanded access approved by the FDA
PerkinElmer Coronavirus RT-PCR test SARS-CoV-2 Emergency Use Authorization approved by the FDA
Quidel Corporation Lyra SARS-CoV-2 Assay SARS-CoV-2 Emergency Use Authorization approved by the FDA
Other Trials
Pliant Therapeutics PLN-1474 nonalcoholic steatohepatitis (NASH) with liver fibrosis dosing of first cohort in phase 1 trial
EOC Pharma eftilagimod alpha (IMP321) metastatic breast cancer completed patient enrollment in phase 1 trial
Allakos subcutaneous antolimab (AK002) healthy subjects initiation of phase 1 trial
Inflazome Inzomelid Cryopyrin-Associated Periodic Syndrome completion of phase 1 study
Ascentage Pharma APG-2575 in combination with rituximab or acalabrutinib relapsed/refractory chronic lymphocytic leukemia or small lymphocytic lymphoma dosing of first subject in phase 1b/2 trial
Allakos antolimab (AK002) active, biopsy-confirmed eosinophilic esophagitis initiation of phase 2/3 trial
Allakos antolimab (AK002) active, biopsy confirmed eosinophilic gastritis and/or eosinophilic duodenitis initiation of phase 3 trial
Avadel Pharmaceuticals FT218 (once-nightly sodium oxybate) excessive daytime sleepiness and cataplexy in patients with narcolepsy completion of phase 3 trial
AgNovos Healthcare AGN1 Local Osteo-enhancement Procedure (LOEP) Small Volume (SV) Kit stable vertebral compression fractures Breakthrough Device designation granted by the FDA
Prevail Therapeutics PR006 to slow the progression of frontotemporal dementia with a GRN mutation (FTD-GRN) Fast-Track designation granted by the FDA
AEGEA Medical Mara Water Vapor Ablation System heavy menstrual bleeding approved by the FDA
Pfizer Eucrisa (crisaborole) ointment, 2% children 3 months of age and older with mild-to-moderate atopic dermatitis sNDA approved by the FDA

 

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing